Anti-Human CD4 Therapeutic Antibody (Zanolimumab)
Recombinant monoclonal antibody to CD4. Zanolimumab (expected trade name HuMax-CD4) is a human monoclonal antibody and an immunosuppressive drug. It is being developed for the treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-039 |
| Pricing | Inquiry |
| Host | Human |
| Target | CD4 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Neut, ELISA, IF, IP, FuncS, FC, IHC |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |